An Introduction to Regulatory Affairs

New

During this one hour presentation I will introduce you to the challenging and diverse topic of regulatory affairs in the pharmaceutical industry and cover some of the aspects we are faced with day to day in the country role. In particular we will look at some of the issues faced with fraudulent and counterfeit medicines and when looking at promotional affairs and product claim development, as these are the two topics for a potential project with Gilead.

About Gilead Sciences Gilead is one of the world's most successful biotech companies with a current market capitalisation of over $150 billion, Gilead Sciences Inc. (www.gilead.com) is a leading research-based biopharmaceutical company which discovers, develops and commercialises innovative medicines in life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver diseases, respiratory diseases, cardiovascular/metabolic diseases, inflammation and oncology

About Alan Collins Alan has 18 years of experience in the pharmaceutical industry and is a Director of Regulatory Affairs at Gilead Sciences. Alan's experience covers the many diverse areas of regulatory affairs, plus pricing and reimbursement, medical affairs, business conduct and auditing - he has never had two working days the same and enjoys the variety and challenge of his role.

Open to all

Lecture

1 hour